BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 38618952)

  • 21. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic regulation and functions of mRNA m6A modification.
    Wang S; Lv W; Li T; Zhang S; Wang H; Li X; Wang L; Ma D; Zang Y; Shen J; Xu Y; Wei W
    Cancer Cell Int; 2022 Jan; 22(1):48. PubMed ID: 35093087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A renal cell carcinoma tumorgraft platform to advance precision medicine.
    Elias R; Tcheuyap VT; Kaushik AK; Singla N; Gao M; Reig Torras O; Christie A; Mulgaonkar A; Woolford L; Stevens C; Kettimuthu KP; Pavia-Jimenez A; Boroughs LK; Joyce A; Dakanali M; Notgrass H; Margulis V; Cadeddu JA; Pedrosa I; Williams NS; Sun X; DeBerardinis RJ; Öz OK; Zhong H; Seshagiri S; Modrusan Z; Cantarel BL; Kapur P; Brugarolas J
    Cell Rep; 2021 Nov; 37(8):110055. PubMed ID: 34818533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The RNA N
    Jin L; Chen C; Yao J; Yu Z; Bu L
    Clin Exp Pharmacol Physiol; 2022 Mar; 49(3):329-340. PubMed ID: 34717005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant activation of m6A demethylase FTO renders HIF2α
    Zhang C; Chen L; Lou W; Su J; Huang J; Liu A; Xu Y; He H; Gao Y; Xu D; Li Q
    Sci Transl Med; 2021 Sep; 13(613):eabf6045. PubMed ID: 34586831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence.
    Peired AJ; Campi R; Angelotti ML; Antonelli G; Conte C; Lazzeri E; Becherucci F; Calistri L; Serni S; Romagnani P
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of telomere homeostasis and genomic stability in cancer by
    Lee JH; Hong J; Zhang Z; de la Peña Avalos B; Proietti CJ; Deamicis AR; Guzmán G P; Lam HM; Garcia J; Roudier MP; Sisk AE; De La Rosa R; Vu K; Yang M; Liao Y; Scheirer J; Pechacek D; Yadav P; Rao MK; Zheng S; Johnson-Pais TL; Leach RJ; Elizalde PV; Dray E; Xu K
    Sci Adv; 2021 Jul; 7(31):. PubMed ID: 34321211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
    Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
    J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PI3K/AKT/mTOR signalling pathway involvement in renal cell carcinoma pathogenesis (Review).
    Miricescu D; Balan DG; Tulin A; Stiru O; Vacaroiu IA; Mihai DA; Popa CC; Papacocea RI; Enyedi M; Sorin NA; Vatachki G; Georgescu DE; Nica AE; Stefani C
    Exp Ther Med; 2021 May; 21(5):540. PubMed ID: 33815613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics.
    Shi R; Ying S; Li Y; Zhu L; Wang X; Jin H
    Cell Death Dis; 2021 Apr; 12(4):346. PubMed ID: 33795663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YTH Domain Proteins: A Family of m
    Xu Y; Zhang W; Shen F; Yang X; Liu H; Dai S; Sun X; Huang J; Guo Q
    Front Oncol; 2021; 11():629560. PubMed ID: 33692959
    [No Abstract]   [Full Text] [Related]  

  • 32. Aberrant expression of m
    Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
    Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Gu Y; Niu S; Wang Y; Duan L; Pan Y; Tong Z; Zhang X; Yang Z; Peng B; Wang X; Han X; Li Y; Cheng T; Liu Y; Shang L; Liu T; Yang X; Sun M; Jiang S; Zhang C; Zhang N; Ye Q; Gao S
    Cancer Res; 2021 Feb; 81(4):923-934. PubMed ID: 33293428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m
    Sun HL; Zhu AC; Gao Y; Terajima H; Fei Q; Liu S; Zhang L; Zhang Z; Harada BT; He YY; Bissonnette MB; Hung MC; He C
    Mol Cell; 2020 Nov; 80(4):633-647.e7. PubMed ID: 33217317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The m
    Xiao Y; Thakkar KN; Zhao H; Broughton J; Li Y; Seoane JA; Diep AN; Metzner TJ; von Eyben R; Dill DL; Brooks JD; Curtis C; Leppert JT; Ye J; Peehl DM; Giaccia AJ; Sinha S; Rankin EB
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21441-21449. PubMed ID: 32817424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIK3R3 regulates ZO-1 expression through the NF-kB pathway in inflammatory bowel disease.
    Ibrahim S; Zhu X; Luo X; Feng Y; Wang J
    Int Immunopharmacol; 2020 Aug; 85():106610. PubMed ID: 32473571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer statistics, 2020.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database.
    Zhou J; Wang J; Hong B; Ma K; Xie H; Li L; Zhang K; Zhou B; Cai L; Gong K
    Aging (Albany NY); 2019 Mar; 11(6):1633-1647. PubMed ID: 30877265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.